This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at email@example.com or call + 1 (702) 988 2320.
Companion diagnostic tests identify specific genetic mutations and biomarkers in individuals who are most likely to benefit from precision medicine treatment, lowering the number of patients who are treated. Companion diagnostics play a pivotal role in the development of targeted medications, and their effectiveness determines the success of this type of therapy to a great extent. Companion diagnostic assays use a single patient as a reference point and will be crucial in the transition to more precise and personalized medication. These are medical gadgets that assist doctors in determining the treatments and dosages to offer patients, based on the patient's individual needs. The companion diagnostic is necessary for the drug's safe and effective use.